Search

  • HOME
  • Search
Focused Issues
1088
GLP-1/GIP수용체작용제: Tirzepatide의 작용기전을 중심으로
오태정
J Korean Diabetes. 2024;25(2):76-81.   Published online June 30, 2024
Opinion
Glucagon-Like Peptide-1수용체작용제의 전 세계적 품절 사태
이동원
J Korean Diabetes. 2024;25(1):1-3.   Published online March 31, 2024
Focused Issues
977
Glucagon-Like Peptide 1 수용체작용제 최신지견
김혜진
J Korean Diabetes. 2021;22(2):126-133.   Published online June 30, 2021
Opinion
삭센다? 열풍, 내분비대사내과 전문의로서의 의견
Sungrae Kim
J Korean Diabetes. 2019;20(2):63-66.   Published online July 17, 2019
Focused Issues
글루카곤양 펩티드-1 수용체 작용제의 임상적 적용
Se Hee Min, Young Min Cho
J Korean Diabetes. 2015;16(4):252-259.   Published online December 24, 2015
인크레틴 계열 약제의 새로운 기전
Seungjoon Oh
J Korean Diabetes. 2013;14(3):120-124.   Published online September 30, 2013

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

  • 5,144 Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
    1,661 Technological Innovations Transforming Diabetes Care in Practice
    3,015 Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning
    1,578 Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity
    1,567 A Young Adult’s Life with Diabetes Based on a Social Ecological Model

    +more

    • KoreaMed
    • KoMCI
    • GoogleScholar
    • Similarity Check
    • Crossref Cited-by Linking
    • CrossMark
    • Funder Registry
    • ORCID


Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2025 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer